awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28080225-8191A2DE-95D7-4A92-8758-25748BC9297E
Q28080225-8191A2DE-95D7-4A92-8758-25748BC9297E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28080225-8191A2DE-95D7-4A92-8758-25748BC9297E
Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C
P2860
Q28080225-8191A2DE-95D7-4A92-8758-25748BC9297E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28080225-8191A2DE-95D7-4A92-8758-25748BC9297E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c205c414a00d77fbbdb3e9591a05e3f08ebd7478
P2860
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.